• Nenhum resultado encontrado

Hormonal therapy and risk of breast cancer in mexican women.

N/A
N/A
Protected

Academic year: 2017

Share "Hormonal therapy and risk of breast cancer in mexican women."

Copied!
7
0
0

Texto

Loading

Imagem

Table 4. OR (95% CI) of breast cancer in premenopausal women according to ever use of hormone contraceptive, and in postmenopausal women according to ever use of hormone replacement therapy, stratified by BMI.

Referências

Documentos relacionados

Association between body mass index and risk of formation of breast cancer in Chinese women. Krebs EE, Taylor BC, Cauley JA, Stone KL, Bowman PJ,

A nested case- control study of adjuvant hormonal therapy persistence and compliance, and early breast cancer recurrence in women with stage I-III breast cancer. Pagani O, Gelber

Regarding drug use and sexual relations, in- fected women had a greater chance of having regular partners who also used drugs as com- pared to infected men (OR = 10.4; 95%CI:

In a previous study 12 , we found that women 70 years of age and older have a higher risk of dying from breast cancer, independent of tumor related factors, in comparison

HORMONE REPLACEMENT THERAPY AND THE RISK OF BREAST CANCER: ASSESSMENT OF THERAPY ACCEPTANCE IN A COHORT OF PREVIOUSLY TREATED BREAST CANCER PATIENTS.. Agnaldo Anelli,

However, patients who undergo conservative therapy for breast cancer with surgery and adjuvant radiotherapy are at increased risk of developing secondary tumors in the breast.. 1

From these results, the authors concluded that risk of breast cancer among HT users was higher in those using the combined estrogen-progestin therapy than in those who

In this prospective study we report on the associations of serum GGT levels with the risk of breast cancer in a pooled population-based cohort of a total of 107,058 women